Ablynx Competitors and Similar CompaniesClear all
Ablynx's competitors and similar companies include Innate Pharma.
 Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. |  Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. | |
Founding Date | Founding Date 2001 | Founding Date 1999 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Gent, BE HQ | Locations Marseille, FR HQ Rockville, US |
Employees | Employees 1252% decrease | Employees 181 |
Financial | ||
Revenue (est.) | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) €2.8m (FY, 2025) |
Net income | Net income (€1.1m) (FY, 2016) | Net income (€49.2m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 498.8m | Total funding raised $ 94.1m |
For sources of this data, please see the company profile
View Company Profiles
Innate Pharma
HQ
Marseille, FR
Employees
181
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View company